These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 580759)

  • 1. The immunosuppressive activity of azathioprine in serum and cerebrospinal fluid.
    Frick E
    Arzneimittelforschung; 1978; 28(3):473-4. PubMed ID: 580759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of azathioprine on antibody formation in mice and its modification by delta-(2-amino-6-hydroxy-3,4-dihydro-4-oxo-5-pyrimidinyl)-valeric acid.
    Svorcová M; Rezábek K; Semonský M
    Arzneimittelforschung; 1980; 30(6):978-80. PubMed ID: 7191277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum immunosuppressive activity of azathioprine in normal subjects and patients with liver diseases.
    Bach JF; Dardenne M
    Proc R Soc Med; 1972 Mar; 65(3):260-3. PubMed ID: 4563301
    [No Abstract]   [Full Text] [Related]  

  • 4. [Electrophoretic study of the cerebrospinal fluid proteins in multiple sclerosis. II. Influence of immunosuppressive chemotherapy].
    Castaigne P; Lhermitte F; Schuller E; Rouques C; Loridan M
    Rev Eur Etud Clin Biol; 1971; 16(7):703-6. PubMed ID: 4107372
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acid hydrolase activity of the blood in immunodepression].
    Drozhennikov VA; Belorusov OS; Tsygankova ST; Kapichnikov MM; Zykov IuV
    Biull Eksp Biol Med; 1984 Apr; 97(4):448-50. PubMed ID: 6372889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Increased cellular antibody synthesis caused by immunosuppressive agents].
    Scheiffarth F; Baenkler HW; Flierl W
    Allerg Immunol (Leipz); 1971; 17(2):132-6. PubMed ID: 4261238
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of cyclosporin A and G with and without azathioprine regarding immunosuppressive efficacy, toxicity, and pharmacokinetics in Lewis rats.
    Hagberg RC; Hoyt EG; Billingham ME; Sibley RK; Starnes VA; Baldwin JC
    J Heart Transplant; 1988; 7(5):359-69. PubMed ID: 3058906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of zinc in forming the immunodepressive effect of imuran].
    Babenko HO; Zaviĭs'kyĭ IuM
    Fiziol Zh (1994); 1996; 42(5-6):51-7. PubMed ID: 9044812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attempt at simplification of the rosette -- inhibition test for routine use in patients under immunosuppressive therapy.
    Nowaczyk M; Laudański Z; Skopińska E
    Ann Med Sect Pol Acad Sci; 1976; (3):159-67. PubMed ID: 973433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic and physical agents. Immunosuppressive agents.
    Elion GB
    Transplant Proc; 1977 Mar; 9(1):975-9. PubMed ID: 325831
    [No Abstract]   [Full Text] [Related]  

  • 11. Azathioprine and methotrexate in multiple sclerosis.
    Fernández O; Fernández V; De Ramón E
    J Neurol Sci; 2004 Aug; 223(1):29-34. PubMed ID: 15261557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of inflammatory gene expression in activated T lymphocytes: a mechanism of immune suppression by thiopurines.
    Thomas CW; Myhre GM; Tschumper R; Sreekumar R; Jelinek D; McKean DJ; Lipsky JJ; Sandborn WJ; Egan LJ
    J Pharmacol Exp Ther; 2005 Feb; 312(2):537-45. PubMed ID: 15388785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The immunosuppressive effect of a heterologous dog antilymphocytic serum].
    Pichlmayr R; Brendel W; Pichlmayr I
    Z Gesamte Exp Med Einschl Exp Chir; 1967; 143(3):313-9. PubMed ID: 4969335
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in the expression of SRBC receptors on human lymphocytes caused by azathioprine and puromycine.
    Drela N
    Arch Immunol Ther Exp (Warsz); 1984; 32(5):565-76. PubMed ID: 6335961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of azathioprine and its metabolites on repair mechanisms of the intestinal epithelium in vitro.
    Schroll S; Sarlette A; Ahrens K; Manns MP; Göke M
    Regul Pept; 2005 Nov; 131(1-3):1-11. PubMed ID: 16122821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of progressive and severe forms of multiple sclerosis using a combination of antilymphocyte serum, azathioprine and prednisone. Clinical and biological results. Comparison with a control group treated with azathioprine and prednisone only. 4-year follow-up].
    Lhermitte F; Marteau R; de Saxcé H
    Rev Neurol (Paris); 1987; 143(2):98-107. PubMed ID: 3299618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of azathioprine on multiple sclerosis new brain lesions evaluated using magnetic resonance imaging.
    Massacesi L; Parigi A; Barilaro A; Repice AM; Pellicanò G; Konze A; Siracusa G; Taiuti R; Amaducci L
    Arch Neurol; 2005 Dec; 62(12):1843-7. PubMed ID: 16344342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of azathioprine and its novel non-mercaptopurine analog on antibody response in rabbits.
    Al-Safi S; Tashtoush B; Hassan M
    Pol J Pharmacol; 2003; 55(2):239-43. PubMed ID: 12926553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The mode of action of immunosuppressive agents. II. Study of the phase of the immunological response sensitive to treatment with azathioprine].
    Bernasconi C; Lazzarino M; Pontiggia P; Introzzi AM
    Riv Emoter Immunoematol; 1967; 14(5):153-62. PubMed ID: 5621345
    [No Abstract]   [Full Text] [Related]  

  • 20. A critical analysis of the use of azathioprine in clinical medicine.
    Ten Berge RJ; Schellekens PT
    Neth J Med; 1983; 26(6):164-71. PubMed ID: 6350911
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.